Roche to halt lung-cancer drug trial after disappointing data

Roche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnRoche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals.